IndraLab

Statements



reach
"Similar to ARF, we found that UV-C, daunorubicin, and doxorubicin repressed the RelA transactivation domain when present as a Gal4 fusion protein."

reach
"We also found that UV-C and daunorubicin repressed the TA2 subdomain (amino acids 428-521) of the RelA transactivation domain."